Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2

1(25.0%)

Early Phase 1

1(25.0%)

N/A

1(25.0%)

Phase 3

1(25.0%)

4Total

Phase 2(1)

Early Phase 1(1)

N/A(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05541172Recruiting

Testosterone Undecanoate Replacement Therapy in Boys With Pubertal Delay or Confirmed Hypogonadism

Role: collaborator

NCT02651844Not ApplicableCompleted

Mifepristone for Breast Cancer Patients With Higher Levels of Progesterone Receptor Isoform A Than Isoform B.

Role: collaborator

NCT04695756Unknown

Liver Transplantation and Coronavirus Disease 2019 (COVID-19)

Role: collaborator

NCT03338777Early Phase 1Terminated

Suicide Plus Immune Gene Therapy for Advanced Melanoma

Role: collaborator

NCT01729663Phase 2Unknown

Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients

Role: collaborator

NCT00799916Phase 3Completed

Saline Solution Versus Voluven®: A Controlled Study of Fluid Resuscitation in Severe Sepsis

Role: collaborator

All 6 trials loaded